Bim is reversibly phosphorylated but plays a limited role in paclitaxel cytotoxicity of breast cancer cell lines

Biochemical and Biophysical Research Communications

Volumn 379, Issue 1, 2009, Pages 145-150

  Czernick, Matt ^a   Rieger, Aja ^a   Goping, Ing Swie ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Apoptosis; BH3; Bim; Paclitaxel; Taxanes

Indexed keywords

BIM PROTEIN; PACLITAXEL;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CELL LINE, TUMOR; CYTOTOXINS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MEMBRANE PROTEINS; MITOSIS; PACLITAXEL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE;

EID: 58149288060     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.12.025     Document Type: Article

References (30)

1. Jordan M.A., and Wilson L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 4 (2004) 253-265
2. Wang T.H., Wang H.S., and Soong Y.K. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 88 (2000) 2619-2628
3. Pellegrini F., and Budman D.R. Review: tubulin function action of antitubulin drugs, and new drug development. Cancer Invest. 23 (2005) 264-273
4. Woods C.M., Zhu J., McQueney P.A., Bollag D., and Lazarides E. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol. Med. 1 (1995) 506-526
5. Jordan M.A., Wendell K., Gardiner S., Derry W.B., Copp H., and Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 56 (1996) 816-825
6. Torres K., and Horwitz S.B. Mechanisms of taxol-induced cell death are concentration dependent. Cancer Res. 58 (1998) 3620-3626
7. Willis S.N., and Adams J.M. Life in the balance. How BH3-only proteins induce apoptosis. Curr. Opin. Cell Biol. 17 (2005) 617-625
8. Bouillet P., and Strasser A. BH3-only proteins - evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J. Cell Sci. 115 (2002) 1567-1574
9. Li Z., Zhang J., Liu Z., Woo C.W., and Thiele C.J. Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death. Cell Death Differ. (2006)
10. Tan T.T., Degenhardt K., Nelson D.A., Beaudoin B., Nieves-Neira W., Bouillet P., Villunger A., Adams J.M., and White E. Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy. Cancer Cell 7 (2005) 227-238
11. Li R., Moudgil T., Ross H.J., and Hu H.M. Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim. Cell Death Differ. 12 (2005) 292-303
12. Sunters A., Fernandez de Mattos S., Stahl M., Brosens J.J., Zoumpoulidou G., Saunders C.A., Coffer P.J., Medema R.H., Coombes R.C., and Lam E.W. FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J. Biol. Chem. 278 (2003) 49795-49805
13. O'Connor L., Strasser A., O'Reilly L.A., Hausmann G., Adams J.M., Cory S., and Huang D.C. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17 (1998) 384-395
14. Li Z., Zhang J., Liu Z., Woo C.W., and Thiele C.J. Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death. Cell Death Differ. 14 (2007) 318-326
15. Ley R., Ewings K.E., Hadfield K., and Cook S.J. Regulatory phosphorylation of Bim: sorting out the ERK from the JNK. Cell Death Differ. 12 (2005) 1008-1014
16. Puthalakath H., and Strasser A. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ. 9 (2002) 505-512
17. Liebmann J., Cook J.A., Teague D., Fisher J., and Mitchell J.B. Cycloheximide inhibits the cytotoxicity of paclitaxel (Taxol). Anticancer Drugs 5 (1994) 287-292
18. Ley R., Ewings K.E., Hadfield K., Howes E., Balmanno K., and Cook S.J. Extracellular signal-regulated kinases 1/2 are serum-stimulated Bim(EL) kinases That bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover. J. Biol. Chem. 279 (2004) 8837-8847
19. Luciano F., Jacquel A., Colosetti P., Herrant M., Cagnol S., Pages G., and Auberger P. Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. Oncogene 22 (2003) 6785-6793
20. Derry W.B., Wilson L., and Jordan M.A. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism. Cancer Res. 58 (1998) 1177-1184
21. Blagosklonny M.V., and Fojo T. Molecular effects of paclitaxel: myths and reality (a critical review). Int. J. Cancer 83 (1999) 151-156
22. Goping I.S., Barry M., Liston P., Sawchuk T., Constantinescu G., Michalak K.M., Shostak I., Roberts D.L., Hunter A.M., Korneluk R., and Bleackley R.C. Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition. Immunity 18 (2003) 355-365
23. Blajeski A.L., Kottke T.J., and Kaufmann S.H. A multistep model for paclitaxel-induced apoptosis in human breast cancer cell lines. Exp. Cell Res. 270 (2001) 277-288
24. Tao W., South V.J., Diehl R.E., Davide J.P., Sepp-Lorenzino L., Fraley M.E., Arrington K.L., and Lobell R.B. An inhibitor of the kinesin spindle protein activates the intrinsic apoptotic pathway independently of p53 and de novo protein synthesis. Mol. Cell. Biol. 27 (2007) 689-698
25. Puthalakath H., Huang D.C., O'Reilly L.A., King S.M., and Strasser A. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell 3 (1999) 287-296
26. Putcha G.V., Le S., Frank S., Besirli C.G., Clark K., Chu B., Alix S., Youle R.J., LaMarche A., Maroney A.C., and Johnson Jr. E.M. JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis. Neuron 38 (2003) 899-914
27. Becker E.B., Howell J., Kodama Y., Barker P.A., and Bonni A. Characterization of the c-Jun N-terminal kinase-BimEL signaling pathway in neuronal apoptosis. J. Neurosci. 24 (2004) 8762-8770
28. Ley R., Balmanno K., Hadfield K., Weston C., and Cook S.J. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein Bim. J. Biol. Chem. 278 (2003) 18811-18816
29. Osborne C.K., Hobbs K., and Trent J.M. Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res. Treat. 9 (1987) 111-121
30. Janicke R.U., Sprengart M.L., Wati M.R., and Porter A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273 (1998) 9357-9360